Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Ribociclib (Ribo) Treatment Adherence Clinical Study Protocol

NCT06344416 is registered in ClinicalTrials.gov with Dosentrx Ltd. as lead sponsor.

NCT NCT06344416
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06344416 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Ribociclib (Ribo) Treatment Adherence Clinical Study Protocol
Lead sponsor
Dosentrx Ltd.
Phase
Not applicable
Overall status
Recruiting
Start date
March 30, 2024
Completion date
January 30, 2026
Enrollment
200 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

any solid oral medication